Back to journals
Academic Journal

AJOB Neuroscience

2 Papers Indexed in Blossom

Data updated

Research Footprint

AJOB Neuroscience has 2 tracked papers indexed in Blossom (2022–2024) from 12 authors, most often covering Psilocybin, across Neurocognitive Disorders, Equity and Ethics and Major Depressive Disorder (MDD).

Published Papers

Open Accessindividual

Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists

This national survey (n=795) in the USA assesses public attitudes towards psilocybin use in licensed settings for psychiatric treatment and well-being enhancement. Participants from across the political spectrum overwhelmingly viewed the individual's decision as morally positive in both contexts, suggesting strong bipartisan support for supervised psilocybin use.

Published
Journal
AJOB Neuroscience
Authors
Sandbrink, J. D., Johnson, K., Gill, M., Yaden, D. B., Savulescu, J., Hannikainen, I. R., Earp, B. D.
Open Accessmeta

Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias

This review (2022) investigates six ethical issues concerning psychedelic medicine and research involving persons living with Alzheimer's Disease (AD)/ADRD, including autonomy, consent, ego dissolution, caregiving, exploitation of patient desperation, and methods to mitigate inequity.

Published
Journal
AJOB Neuroscience
Authors
Peterson, A., Largent, E. A., Sisti, D., Karlawish, J., Lynch, H. F.

Quick Facts

Papers Indexed
2
h-Index
34
Open Access
No
Publisher
Taylor & Francis
Country
United States
Website
Visit